This study is in progress, not accepting new patients
Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis
Summary
- Eligibility
- for people ages 40 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Pliant Therapeutics, Inc.
- Links
- Trial website
- ID
- NCT06097260
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 360 study participants
- Last Updated